Bone Density, Low
12
2
2
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
33%
4 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (12)
The Effect of the Probiotic Strains on Bone Mineral Density in Postmenopausal Women
FARE Augmentation of Proximal Femoral Fractures With CaS/HA and Systemic ZA
CT-Based Changes in Bone and Marrow Among Patients on Oral Steroids
Effects of Romosozumab on Bone Density in Women With Anorexia Nervosa
Efficacy of Intensive Cholecalciferol Monitoring and Supplementation on Serum vitD Levels in Pediatric Patients With CF
Bone Mineral Density in Children With Graves' Disease
Effects of OsteoStrong vs. Individually Adapted and Combined Training on Bone Health
Comparing the Hydrodynamic Piezoelectric Technique With Osseodensification for the Assessment of Internal Sinus Iift-ing
Relation Between Bone Mineral Density, Gross Motor Function and Quality of Life In Children With Cerebral Palsy
Effects of Vitamin D on the Behaviours, Mental, and Physical Health of Prisoners
Effects of Soy Isoflavone on Bone Health Among Saudi Female Students Imam Abdulrahman Bin Faisal University.
Denosumab Treatment in CKD Patients at High Risk of Fracture